Department of Ophthalmology, University of Rome, Campus Bio-Medico, Rome, Italy.
Ophthalmology. 2010 Jul;117(7):1294-9. doi: 10.1016/j.ophtha.2009.11.043. Epub 2010 Apr 10.
To develop a standardized clinical grading system for the management of patients with vernal keratoconjunctivitis (VKC) and to identify the risk factors associated with a worsened outcome of the disease, including decrease of visual acuity and ocular complications development.
Retrospective cohort study.
A total of 207 consecutive patients with VKC, referred to our Cornea and External Diseases Center from 1997 to 2007, were included in the study. A total of 110 of those patients were included in the follow-up study (range 1-10 years).
Classification and regression tree (CART) analysis was performed to separate the patients into 5 subgroups by therapeutic approach. Regression tree and multivariate logistic regression analyses were performed during follow-up to identify predictors of worse visual outcome.
Age, gender, duration and course of disease, signs, symptoms, overall symptoms score, history of atopy, markers of allergy, best-corrected visual acuity, and therapy were collected at baseline and during follow-up. The number of relapses and number of patients with decreased visual acuity were also evaluated in the follow-up.
A decision tree for VKC treatment was developed by CART analysis, and a new clinical grading system was proposed accordingly. Sixteen patients were classified as grade 0 (absence of symptoms and no therapy); 59 patients were classified as grade 1 (presence of symptoms without photophobia, occasional use of anti-allergic eye drop); 74 patients were classified as grade 2 (presence of symptoms including photophobia, daily anti-allergic treatment); 22 patients with superficial punctuate keratopathy (SPK) were classified as grade 3 (daily anti-allergic treatment associated with occasional topical steroid); and 36 patients were classified as grade 4 (diffuse SPK or corneal ulcer; pulsed high-dose topical steroid). A higher number of relapses and a higher baseline grade of VKC were the main predictor factors for worse visual outcome.
This grading system allows for identifying the more severe forms of VKC that are at higher risk of recurrences, corneal ulceration, and worse final visual outcome.
FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
制定一种用于春季角结膜炎(VKC)患者管理的标准化临床分级系统,并确定与疾病恶化结局相关的风险因素,包括视力下降和眼部并发症的发生。
回顾性队列研究。
本研究纳入了 207 例于 1997 年至 2007 年期间就诊于我们的角膜和眼表疾病中心的 VKC 连续患者,其中 110 例患者纳入随访研究(随访时间 1-10 年)。
采用分类回归树(CART)分析,根据治疗方法将患者分为 5 组。在随访期间进行回归树和多变量逻辑回归分析,以确定视觉预后不良的预测因素。
年龄、性别、疾病持续时间和病程、体征、症状、总体症状评分、特应性病史、过敏标志物、最佳矫正视力以及治疗方法在基线和随访时均被收集。在随访中还评估了复发次数和视力下降患者的数量。
通过 CART 分析制定了 VKC 治疗决策树,并相应提出了新的临床分级系统。16 例患者被归类为 0 级(无症状且无需治疗);59 例患者被归类为 1 级(存在症状但无畏光,偶尔使用抗过敏滴眼剂);74 例患者被归类为 2 级(存在症状包括畏光,每日抗过敏治疗);22 例浅层点状角膜病变(SPK)患者被归类为 3 级(每日抗过敏治疗,偶尔使用局部皮质类固醇);36 例患者被归类为 4 级(弥漫性 SPK 或角膜溃疡;脉冲高剂量局部皮质类固醇)。更多的复发次数和更高的 VKC 基线分级是视觉预后不良的主要预测因素。
该分级系统可识别出更严重的 VKC 类型,这些类型更易复发、发生角膜溃疡和视力预后更差。
作者未在本文讨论的任何材料中拥有专有权或商业利益。